MSCs Therapy Reverse the Gut Microbiota in Hypoxia-Induced Pulmonary Hypertension Mice
Mesenchymal stem cell (MSC) therapy is a promising therapeutic approach based on its strong effect on pulmonary hypertension (PH) in rats. However, the detailed mechanism of MSC therapy remains unknown. Alterations in the gut microbiota were found in both type 1 pulmonary arterial hypertension patie...
Main Authors: | Lingjie Luo, Qinhua Chen, Lei Yang, Zhenxia Zhang, Jihong Xu, Deming Gou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2021.712139/full |
Similar Items
-
Gut Microbiota and Metabolome Changes in Three Pulmonary Hypertension Rat Models
by: Lingjie Luo, et al.
Published: (2023-02-01) -
Mesenchymal stem cell-derived exosomes promote tissue repair injury in rats with liver trauma by regulating gut microbiota and metabolism
by: Bo Yi, et al.
Published: (2024-06-01) -
The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension
by: Yi-Hang Chen, et al.
Published: (2022-10-01) -
Gut Microbiota Feature of Senile Osteoporosis by Shallow Shotgun Sequencing Using Aged Rats Model
by: Ning Wang, et al.
Published: (2022-03-01) -
The Role of Gut and Airway Microbiota in Pulmonary Arterial Hypertension
by: Linlin Huang, et al.
Published: (2022-07-01)